A Randomized, Single-blind, Propofol-controlled Phase III Study Evaluating the Efficacy and Safety of Remimazolam in General Anesthesia in Adult Patients Undergoing Cardiac Surgery, Including Follow-up Sedation in the Post-anesthesia Care Unit / Intensive Care Unit

Trial Profile

A Randomized, Single-blind, Propofol-controlled Phase III Study Evaluating the Efficacy and Safety of Remimazolam in General Anesthesia in Adult Patients Undergoing Cardiac Surgery, Including Follow-up Sedation in the Post-anesthesia Care Unit / Intensive Care Unit

Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Aug 2017

At a glance

  • Drugs Remimazolam (Primary) ; Propofol
  • Indications Sedation
  • Focus Therapeutic Use
  • Sponsors PAION
  • Most Recent Events

    • 09 Mar 2017 Trial has been completed in Germany (7 March 2016).
    • 22 Mar 2016 Status changed from recruiting to discontinued due to poor recruitment as reported by ClinicalTrials.gov.
    • 15 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top